
Amazon Prime Day Lifts Retailers Ahead of Key Inflation Data, and the Three Stocks that One Chart Watcher Says Are Ready to Bounce 7/11/23
CNBC's "Fast Money"
00:00
Lilly and Novo Nordisk Under Pressure After New Analysis Found That Only One Third of Patients Continued Treatment Beyond One Year
Lilly and Novo Nordisk under pressure after new analysis found that only one third of patients continued treatment beyond one year. Research from Prime Therapeutics also found that annual healthcare costs spiked. European regulators are looking into the risks of suicidal thoughts by users of these drugs.
Play episode from 24:18
Transcript


